Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
Cytomegalovirus (CMV) infections may increase morbidity and mortality in immunocompromised patients. Until recently, standard antiviral drugs against CMV were limited to viral DNA polymerase inhibitors (val)ganciclovir, foscarnet and cidofovir with a risk for cross-resistance. These drugs may also c...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2024-01-01
|
| Serier: | Infectious Disease Reports |
| Fag: | |
| Online adgang: | https://www.mdpi.com/2036-7449/16/1/5 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
